Information  X 
Enter a valid email address

Hikma Pharm PLC Ord Shs 10P (HIK)

Date Time Source Announcement
23 May 2018 10:20 am
RNS
Director/PDMR Shareholding
18 May 2018 1:01 pm
RNS
AGM Results
  7:00 am
RNS
Trading Statement
17 May 2018 1:45 pm
RNS
Director/PDMR Shareholding
  1:10 pm
RNS
Director/PDMR Shareholding
15 May 2018 2:26 pm
RNS
Director/PDMR Shareholding
03 May 2018 9:00 am
RNS
Hikma launches Methotrexate Injection
01 May 2018 1:38 pm
RNS
Total Voting Rights
26 Apr 2018 1:40 pm
RNS
Holding(s) in Company
25 Apr 2018 10:41 am
RNS
Block listing Interim Review
24 Apr 2018 9:00 am
RNS
Hikma expands licensing agreement with Rovi
20 Apr 2018 9:00 am
RNS
Hikma launches Dexrazoxane for Injection
19 Apr 2018 12:00 pm
RNS
Annual Financial Report and Notice of AGM
10 Apr 2018 2:34 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 11:19 am
RNS
Total Voting Rights
29 Mar 2018 9:00 am
RNS
Hikma launch-Palonosetron Hydrochloride Injection
20 Mar 2018 9:00 am
RNS
Hikma has launched Ritonavir Tablets USP
19 Mar 2018 3:50 pm
RNS
Director/PDMR Shareholding
14 Mar 2018 7:00 am
RNS
Final Results
12 Mar 2018 7:00 am
RNS
Update status on ANDA for generic Advair Diskus?
09 Mar 2018 9:21 am
RNS
Block Listing Application
27 Feb 2018 12:23 pm
RNS
Notice of Results
20 Feb 2018 7:00 am
RNS
Sigurdur Olafsson appointed CEO of Hikma
13 Feb 2018 4:43 pm
RNS
Holding(s) in Company
08 Feb 2018 12:41 pm
RNS
Director/PDMR Shareholding
  12:39 pm
RNS
Director/PDMR Shareholding
  12:37 pm
RNS
Director/PDMR Shareholding
26 Jan 2018 4:56 pm
RNS
Holding(s) in Company
17 Jan 2018 5:22 pm
RNS
Holding(s) in Company
15 Jan 2018 8:00 am
RNS
Hikma Appoints Dr. Surendera Tyagi
04 Jan 2018 11:19 am
RNS
Total Voting Rights
19 Dec 2017 9:00 am
RNS
Hikma reaches licensing agreement with Celltrion
13 Dec 2017 9:00 am
RNS
Hikma- Dihydroergotamine Mesylate Injection, USP
12 Dec 2017 9:59 am
RNS
Holding(s) in Company
11 Dec 2017 9:33 am
RNS
Holding(s) in Company
01 Dec 2017 9:28 am
RNS
Total Voting Rights
30 Nov 2017 5:47 pm
RNS
Hikma Ventures- $20.5m Series C round for Prognos
28 Nov 2017 10:24 am
RNS
Announcement
27 Nov 2017 1:38 pm
RNS
Hikma Ventures invests in Biolinq
22 Nov 2017 9:32 am
RNS
Holding(s) in Company
20 Nov 2017 9:32 am
RNS
Holding(s) in Company
14 Nov 2017 8:47 am
RNS
Holding(s) in Company
  7:00 am
RNS
Hikma Acquires Products from Boehringer Ingelheim
09 Nov 2017 7:00 am
RNS
Trading Statement
08 Nov 2017 4:45 pm
RNS
Holding(s) in Company
03 Nov 2017 9:00 am
RNS
Hikma launches Flucytosine Capsules USP in US
02 Nov 2017 2:51 pm
RNS
Holding(s) in Company
01 Nov 2017 11:43 am
RNS
Total Voting Rights
30 Oct 2017 9:26 am
RNS
Hikma launches Pantoprazole Sodium for Injection
05 Oct 2017 9:49 am
RNS
Block listing Interim Review
02 Oct 2017 3:36 pm
RNS
Total Voting Rights
28 Sep 2017 3:29 pm
RNS
Holding(s) in Company
25 Sep 2017 11:27 am
RNS
Holding(s) in Company
14 Sep 2017 3:52 pm
RNS
Holding(s) in Company
25 Aug 2017 8:41 am
RNS
Holding(s) in Company
17 Aug 2017 7:00 am
RNS
Hikma announces licensing agreement with Takeda
  7:00 am
RNS
Half-year Report
10 Aug 2017 10:05 am
RNS
Director/PDMR Shareholding
  10:02 am
RNS
Director/PDMR Shareholding
09 Aug 2017 9:54 am
RNS
Director/PDMR Shareholding
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t